Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Cancer Immunology, Immunotherapy : CII
|
January 9, 2022
Combination immunotherapy including OncoVEX<sup>mGMCSF</sup> creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma
Robyn D Gartrell, Zoë Blake, Emanuelle M Rizk, et al.
Journal for Immunotherapy of Cancer
|
December 25, 2024
Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings
Brian S Henick, Peter D Koch, Justin F Gainor, et al.
JNCI Cancer Spectrum
|
July 11, 2024
Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa
Kara I Cicero, Xolisile Dlamini, Yvonne Mavengere, et al.
Frontiers in Oncology
|
September 15, 2022
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
Shaheer Khan, Jose Lutzky, Alexander N Shoushtari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial
Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.
Nature Cancer
|
December 30, 2022
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, et al.
Muscle & Nerve
|
November 24, 2019
Primary lateral sclerosis (PLS) functional rating scale: PLS-specific clinimetric scale
Hiroshi Mitsumoto, Codruta Chiuzan, Madison Gilmore, et al.
Oncoimmunology
|
May 13, 2022
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
Robyn D Gartrell, Thomas Enzler, Pan S Kim, et al.
Journal for Immunotherapy of Cancer
|
March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Cancer Immunology, Immunotherapy : CII
|
January 9, 2022
Combination immunotherapy including OncoVEX<sup>mGMCSF</sup> creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma
Robyn D Gartrell, Zoë Blake, Emanuelle M Rizk, et al.
Journal for Immunotherapy of Cancer
|
December 25, 2024
Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings
Brian S Henick, Peter D Koch, Justin F Gainor, et al.
JNCI Cancer Spectrum
|
July 11, 2024
Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa
Kara I Cicero, Xolisile Dlamini, Yvonne Mavengere, et al.
Frontiers in Oncology
|
September 15, 2022
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
Shaheer Khan, Jose Lutzky, Alexander N Shoushtari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial
Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.
Nature Cancer
|
December 30, 2022
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, et al.
Muscle & Nerve
|
November 24, 2019
Primary lateral sclerosis (PLS) functional rating scale: PLS-specific clinimetric scale
Hiroshi Mitsumoto, Codruta Chiuzan, Madison Gilmore, et al.
Oncoimmunology
|
May 13, 2022
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
Robyn D Gartrell, Thomas Enzler, Pan S Kim, et al.
Journal for Immunotherapy of Cancer
|
March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Page
of 6